Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Combination of chemotherapeutic agents and biological response modifiers (immunotherapy) in triple-negative/Her2( +) breast cancer, multiple myeloma, and non-small-cell lung cancer.
Journal: Journal of the Egyptian National Cancer Institute
Published: January 25, 2022
Showing 1-2 of 2
Last Updated: 09/26/2026